Frontiers in Oncology | Molecular and Cellular Oncology

Original Research

Published on 23 Dec 2022

Comprehensive analysis of the significance of METTL7A gene in the prognosis of lung adenocarcinoma

in Molecular and Cellular Oncology

Ya-Qiang Pan
Ying Xiao
Zhenhua Li
Long Tao
Ge Chen
Jing-Feng Zhu
Lu Lv
Jian-Chao Liu
Jun-Qing Qi
AiZhong Shao

Frontiers in Oncology

doi 10.3389/fonc.2022.1071100

4,008 views
5 citations

Original Research

Published on 23 Dec 2022

A pyroptosis-related gene signature for prognostic and immunological evaluation in breast cancer

in Molecular and Cellular Oncology

Yue Zhong
Fu Peng
Xiaoru Luo
Xuan Wang
Bowen Yang
Xinglinzi Tang
Zheng Xu
Linlin Ren
Zhiyu Wang
Cheng Peng

Frontiers in Oncology

doi 10.3389/fonc.2022.964508

3,907 views
2 citations

Review

Published on 22 Dec 2022

TRIM31: A molecule with a dual role in cancer

in Molecular and Cellular Oncology

Yafei Guo
Ping Lin
Yimin Hua
Chuan Wang

Frontiers in Oncology

doi 10.3389/fonc.2022.1047177

6,191 views
14 citations

Original Research

Published on 22 Dec 2022

Comprehensive analysis of cuproptosis-related long non-coding RNA signature and personalized therapeutic strategy of breast cancer patients

in Molecular and Cellular Oncology

Qiaonan Guo
Pengjun Qiu
Kelun Pan
Jianqing Lin

Frontiers in Oncology

doi 10.3389/fonc.2022.1081089

3,301 views
7 citations

Editorial

Published on 22 Dec 2022

Editorial: Ion channels & homeostasis of ions in cancer cell fate

in Molecular and Cellular Oncology

Wei Cheng
Linlin Ma
Zui Pan

Frontiers in Oncology

doi 10.3389/fonc.2022.1090583

1,570 views

Mini Review

Published on 22 Dec 2022

Soluble HLA peptidome: A new resource for cancer biomarkers

in Molecular and Cellular Oncology

Erwin Tanuwidjaya
Ralf B. Schittenhelm
Pouya Faridi

Frontiers in Oncology

doi 10.3389/fonc.2022.1069635

3,340 views
6 citations

Original Research

Published on 21 Dec 2022

NUF2 overexpression contributes to epithelial ovarian cancer progression via ERBB3-mediated PI3K-AKT and MAPK signaling axes

in Molecular and Cellular Oncology

Ruobing Leng
Yunfang Meng
Xiaomei Sun
Yingzi Zhao

Frontiers in Oncology

doi 10.3389/fonc.2022.1057198

2,858 views
13 citations

Mini Review

Published on 20 Dec 2022

Molecular features of aggressive thyroid cancer

in Molecular and Cellular Oncology

Giusy Elia
Armando Patrizio
Francesca Ragusa
Sabrina Rosaria Paparo
Valeria Mazzi
Eugenia Balestri
Chiara Botrini
Licia Rugani
Salvatore Benvenga
Gabriele Materazzi

Frontiers in Oncology

doi 10.3389/fonc.2022.1099280

8,105 views
23 citations

Mini Review

Published on 20 Dec 2022

Succinylation and redox status in cancer cells

in Molecular and Cellular Oncology

Xiaofeng Dai
Yanyan Zhou
Fei Han
Jitian Li

Frontiers in Oncology

doi 10.3389/fonc.2022.1081712

7,519 views
22 citations

Original Research

Published on 19 Dec 2022

Identification of potential target genes of honokiol in overcoming breast cancer resistance to tamoxifen

in Molecular and Cellular Oncology

Adam Hermawan
Herwandhani Putri
Naufa Hanif
Nurul Fatimah
Heri Himawan Prasetio

Frontiers in Oncology

doi 10.3389/fonc.2022.1019025

3,702 views
8 citations

Original Research

Published on 15 Dec 2022

The integrative bioinformatics approaches to predict the xanthohumol as anti-breast cancer molecule: Targeting cancer cells signaling PI3K and AKT kinase pathway

in Molecular and Cellular Oncology

Kartikey Kumar Gupta
Kamal Kant Sharma
Harish Chandra
Himalaya Panwar
Nitin Bhardwaj
Najla A. Altwaijry
Aisha A. Alsfouk
Zodwa Dlamini
Obaid Afzal
Abdulmalik S. A. Altamimi

Frontiers in Oncology

doi 10.3389/fonc.2022.950835

3,410 views
10 citations

Case Report

Published on 15 Dec 2022

EWSR1::SMAD3-rearranged fibroblastic tumor: A case with twice recurrence and literature review

in Molecular and Cellular Oncology

Li Yang
Linni Fan
Zhiyong Yin
Yixiong Liu
Danhui Zhao
Zhe Wang
Hong Cheng

Frontiers in Oncology

doi 10.3389/fonc.2022.1017310

2,854 views
3 citations

Review

Published on 15 Dec 2022

Application of engineered extracellular vesicles to overcome drug resistance in cancer

in Molecular and Cellular Oncology

Taichiro Nonaka

Frontiers in Oncology

doi 10.3389/fonc.2022.1070479

2,288 views
4 citations

Original Research

Published on 14 Dec 2022

Plasma exosomal miR-320d, miR-4479, and miR-6763-5p as diagnostic biomarkers in epithelial ovarian cancer

in Molecular and Cellular Oncology

Shiwen Wang
Xingguo Song
Kangyu Wang
Baibing Zheng
Qinghai Lin
Miao Yu
Li Xie
Liang Chen
Xianrang Song

Frontiers in Oncology

doi 10.3389/fonc.2022.986343

2,473 views
21 citations

Review

Published on 14 Dec 2022

Exosomal long non-coding RNAs: novel molecules in gastrointestinal cancers’ progression and diagnosis

in Molecular and Cellular Oncology

Mohammad Roshani
Ghazaleh Baniebrahimi
Mahboubeh Mousavi
Noushid Zare
Reza Sadeghi
Reza Salarinia
Amirhossein Sheida
Danial Molavizadeh
Sara Sadeghi
Farzaneh Moammer

Frontiers in Oncology

doi 10.3389/fonc.2022.1014949

5,377 views
15 citations

Original Research

Published on 14 Dec 2022

BTG2 suppresses renal cell carcinoma progression through N6-methyladenosine

in Molecular and Cellular Oncology

Fuming Qi
Wenlong Liu
Bo Tan
Juan Zhang
Yan Ma
Congcong Cao
Fujun Ma
Bo Zhu
Jinhui Yang
Xiaoyun Liu

Frontiers in Oncology

doi 10.3389/fonc.2022.1049928

2,748 views
11 citations